Literature DB >> 23299219

Coagulopathy disproportionately predisposes to lobar intracerebral hemorrhage.

Matthew B Maas1, Neil F Rosenberg, Adam R Kosteva, Shyam Prabhakaran, Andrew M Naidech.   

Abstract

BACKGROUND: Anticoagulation increases the risk of intracerebral hemorrhage (ICH), yet whether different underlying disease processes are equally affected is unknown. We tested the hypothesis that coagulopathy, measured by admission international normalized ratio (INR), disproportionately increases the risk for lobar hemorrhages.
METHODS: Patients with primary ICH were enrolled into a registry between December 2006 and February 2012 with prospective data acquisition and systematic follow up. Logistic regression was used to test whether lobar versus deep ICH location was independently associated with INR, and then whether INR had an influence on mortality. Spearman's correlation coefficient was used to test for an association between INR and hematoma volume separately in the lobar and deep ICH groups.
RESULTS: 221 patients were studied. Patients with lobar ICH were older (71 vs. 62 years old, p < 0.001) and more likely to have prior ICH (10 vs. 0 %, p < 0.001). INR >1.4 was observed on admission more frequently in lobar versus deep ICH (19 vs. 8 %, p = 0.02). Lobar ICH location was independently associated with INR >1.4 (OR: 2.51, 95 % CI: 1.03-6.14, p = 0.043). ICH volume correlated with INR in lobar ICH (p = 0.009), but not deep ICH (p = 0.8). Death at 1 month was independently associated with INR >1.4 (OR: 7.6, 95 % CI: 2.4-24.1, p = 0.001) after correction for the ICH Score.
CONCLUSIONS: Abnormal coagulation occurs disproportionally in lobar versus deep ICH, and is associated with larger ICH volumes and higher mortality. These findings suggest a unique risk interaction between coagulopathy and underlying brain pathology due to cerebral amyloid angiopathy.

Entities:  

Mesh:

Year:  2013        PMID: 23299219     DOI: 10.1007/s12028-012-9814-x

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  13 in total

1.  What causes intracerebral hemorrhage during warfarin therapy?

Authors:  R G Hart
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

2.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

Authors:  R O Weller; A Massey; T A Newman; M Hutchings; Y M Kuo; A E Roher
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

3.  The increasing incidence of anticoagulant-associated intracerebral hemorrhage.

Authors:  M L Flaherty; B Kissela; D Woo; D Kleindorfer; K Alwell; P Sekar; C J Moomaw; M Haverbusch; J P Broderick
Journal:  Neurology       Date:  2007-01-09       Impact factor: 9.910

4.  Location and outcome of anticoagulant-associated intracerebral hemorrhage.

Authors:  Matthew L Flaherty; Mary Haverbusch; Padmini Sekar; Brett M Kissela; Dawn Kleindorfer; Charles J Moomaw; Joseph P Broderick; Daniel Woo
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

5.  Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study.

Authors:  Mariëlle M F Poels; M Arfan Ikram; Aad van der Lugt; Albert Hofman; Gabriel P Krestin; Monique M B Breteler; Meike W Vernooij
Journal:  Stroke       Date:  2011-02-09       Impact factor: 7.914

6.  The ICH score: a simple, reliable grading scale for intracerebral hemorrhage.

Authors:  J C Hemphill; D C Bonovich; L Besmertis; G T Manley; S C Johnston
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

7.  Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage.

Authors:  J J Flibotte; N Hagan; J O'Donnell; S M Greenberg; J Rosand
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

8.  Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage.

Authors:  Seung-Hoon Lee; Wi-Sun Ryu; Jae-Kyu Roh
Journal:  Neurology       Date:  2009-01-13       Impact factor: 9.910

9.  Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?

Authors:  Mark H Eckman; Lawrence K S Wong; Yannie O Y Soo; Wynnie Lam; Song Ran Yang; Steven M Greenberg; Jonathan Rosand
Journal:  Stroke       Date:  2008-10-09       Impact factor: 7.914

10.  Prospective validation of the ICH Score for 12-month functional outcome.

Authors:  J Claude Hemphill; Mary Farrant; Terry A Neill
Journal:  Neurology       Date:  2009-09-02       Impact factor: 9.910

View more
  4 in total

Review 1.  Use of anticoagulant therapy and cerebral microbleeds: a systematic review and meta-analysis.

Authors:  Yajun Cheng; Yanan Wang; Quhong Song; Ke Qiu; Ming Liu
Journal:  J Neurol       Date:  2019-10-15       Impact factor: 4.849

Review 2.  Hematoma Expansion Following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation.

Authors:  Sherrefa R Burchell; Jiping Tang; John H Zhang
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 3.  The Role of Serum Calcium Level in Intracerebral Hemorrhage Hematoma Expansion: Is There Any?

Authors:  Mostafa Jafari; Mario Di Napoli; Yvonne H Datta; Eric M Bershad; Afshin A Divani
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210

4.  Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease.

Authors:  Philip H C Kremer; Wilmar M T Jolink; L Jaap Kappelle; Ale Algra; Catharina J M Klijn
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.